|
NUP54 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.95399252334028E-13 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
1.271840E-01 |
| Stage1-vs-Stage3 |
2.709800E-01 |
| Stage1-vs-Stage4 |
1.169610E-02 |
| Stage2-vs-Stage3 |
5.287000E-01 |
| Stage2-vs-Stage4 |
7.133600E-01 |
| Stage3-vs-Stage4 |
2.119000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.87839999951944E-07 |
| Normal-vs-Asian |
1.65640001714706E-09 |
| Caucasian-vs-AfricanAmerican |
3.128800E-01 |
| Caucasian-vs-Asian |
6.221600E-02 |
| AfricanAmerican-vs-Asian |
7.517000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
4.176000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
1.607930E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.517800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.700430E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.912000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.639960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.192600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.396800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.130370E-01 |
| Classical-VS-Follicular |
1.368890E-04 |
| Classical-VS-Other |
6.060000E-01 |
| Classical-VS-Normal |
3.97926136486149E-12 |
| Tall-VS-Follicular |
2.728800E-01 |
| Tall-VS-Other |
7.930800E-01 |
| Tall-VS-Normal |
2.50980014548929E-10 |
| Follicular-VS-Other |
4.215200E-01 |
| Follicular-VS-Normal |
1.62447832963153E-12 |
| Other-VS-Normal |
8.425100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.06581410364015E-14 |
| N0-vs-N1 |
7.152000E-01 |
|
|
